STARMER CUTS DOCTOR APPRENTICESHIP SCHEME
The government has decided to end a medical apprenticeship program that allowed low-income students to get medical training without taking out loans. The scheme, launched under the previous Conservative government in 2023, aimed to make the profession more accessible, diverse, and representative of local communities. Apprentices were paid a salary Continue Reading
Ramsay’s dedication to helping Restaurants
Gordon Ramsay is a renowned British chef, television personality, and restaurateur known for his fiery temper and high culinary standards. His series “Kitchen Nightmares,” which premiered in the UK in 2004 and later had an American version starting in 2007, showcases Ramsay visiting struggling restaurants to help them identify and Continue Reading
THE RISE OF COCAINE IN THE UK
Between 2022 and 2023, cocaine-related deaths in England and Wales soared by 30%, according to the latest United Nations Office on Drugs and Crime report. This could be an underestimate, as there is often a time lag of two to three years between drug deaths and the coroner’s assessment on Continue Reading
CHRIS HOY ANNOUNCES HIS CANCER IS TERMINAL
The six-time Olympic champion, who was initially diagnosed with prostate cancer, shared that the disease has spread to other parts of his body and is incurable. He has been given a prognosis of two to four years to live. Hoy has been undergoing treatment to manage the disease, but despite Continue Reading
HOW THE MANIFESTOS STACK AGAINST NHS BILL
The parties’ manifestos, including the contract Reform UK, and Labour, have been released, and the campaigns are entering the final straight. However, many of the numbers floating around are close to useless, particularly regarding the next government’s spending plans on public services. The NHS is the largest public service often Continue Reading
NOVO NORDISK SUSPENDED IN UK OVER DIET DRUG STUDY
Novo Nordisk, a Danish pharmaceutical company, has been suspended from the UK’s pharma trade body for not being transparent in its promotion of its weight-loss predecessor, liraglutide, to doctors. The company is currently involved in a study that found that its weight-loss drug semaglutide reduces the risk of heart attacks, Continue Reading
